Market revenue in 2023 | USD 172.5 million |
Market revenue in 2030 | USD 288.1 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 64.35% in 2023. Horizon Databook has segmented the Mexico veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Stringent government regulations for animals that depend on people for their existence is anticipated to fuel the veterinary API manufacturing market growth in Mexico. For instance, the needless death of an animal is considered illegal under the Domestic Animal Protection Act of 2016.
Furthermore, increased measures to curb zoonotic disease outbreaks are expected to boost the market. For instance, Dispositivo Nacional de Emergencia de Sanidad Animal (DINESA) is an animal health emergency management system that works to prevent and control highly prevalent zoonotic diseases.
Moreover, Mexico has an efficient surveillance system that helps prevent and address animal health emergencies caused by pathogens. This is anticipated to generate high demand for highquality animal products, creating lucrative growth opportunities in the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account